(Q62.2) Congenital megaloureter

More details coming soon

Icon
1 286 489 in individuals diagnosis congenital megaloureter confirmed
Icon
1 908 deaths with diagnosis congenital megaloureter

Diagnosis congenital megaloureter is diagnosed Men are 19.32% more likely than Women

767 515

Men receive the diagnosis congenital megaloureter

1 252 (0.2 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
518 974

Women receive the diagnosis congenital megaloureter

656 (0.1 %)

Died from this diagnosis.

Risk Group for the Disease congenital megaloureter - Men and Women aged 0

Icon
In Men diagnosis is most often set at age 0-89, 95+
Icon
Less common in men the disease occurs at Age 90-94Less common in women the disease occurs at Age 85-89, 95+
Icon
In Women diagnosis is most often set at age 0-84, 90-94

Disease Features congenital megaloureter

Icon
Absence or low individual and public risk
Icon

Congenital megaloureter - what does this mean

Congenital megaloureter is a condition that occurs when the ureter (the tube that carries urine from the kidney to the bladder) becomes abnormally enlarged. it is caused by an obstruction in the ureter, which can be due to a birth defect, a tumor, or other medical conditions.

What happens during the disease - congenital megaloureter

Congenital megaloureter is a rare condition caused by a blockage of the ureter, usually due to a ureteropelvic junction obstruction or a ureterovesical junction obstruction. this blockage causes an accumulation of urine in the ureter, which causes it to become enlarged. this can lead to a variety of complications such as urinary tract infections, kidney damage, and even kidney failure if left untreated.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination
  • Ultrasound imaging
  • Voiding cystourethrogram (VCUG)
  • Intravenous pyelogram (IVP)
  • Retrograde pyelogram
  • Computed tomography (CT) scan
  • Magnetic resonance imaging (MRI) scan
  • Renal scintigraphy

Treatment and Medical Assistance

Main Goal: Treating Congenital Megaloureter
  • Identify underlying cause of the megaloureter
  • Perform imaging tests to assess the size and shape of the affected ureter
  • Prescribe antibiotics to reduce infection
  • Prescribe medications to reduce inflammation
  • Perform minimally invasive surgery to correct the ureter's abnormality
  • Administer a ureteral stent to keep the ureter open
  • Perform open surgery to correct the ureter's abnormality
  • Administer intravenous fluids to maintain hydration
  • Prescribe a low-sodium diet to reduce fluid retention
  • Monitor the patient's condition regularly
Icon
9 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Congenital megaloureter - Prevention

The best way to prevent congenital megaloureter is to ensure that pregnant women receive adequate prenatal care, including regular ultrasounds to monitor the development of the fetus and any potential abnormalities. in addition, women should be aware of any risk factors for the condition, such as diabetes or a family history of the disease, and should consult with their doctor if they have any concerns.

Specified forms of the disease

(D17.0) Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
(D17.1) Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
(D17.2) Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
(D17.3) Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites
(D17.4) Benign lipomatous neoplasm of intrathoracic organs
(D17.5) Benign lipomatous neoplasm of intra-abdominal organs
(D17.6) Benign lipomatous neoplasm of spermatic cord
(D17.7) Benign lipomatous neoplasm of other sites
(D17.9) Benign lipomatous neoplasm, unspecified